Because SUMOylation is involved in ATF3-mediated CCND1/2 activation and CCND activity is required for cell cycle progression, we next investigated the potential role of SUMOylation of ATF3 in proliferation of prostate cancer cells. This evidence concerns the gene ATF3 and prostate carcinoma.